News for Windtree Therapeutics, Inc. (WINTW)

Windtree Therapeutics (WINT) has announced that its board has approved the implementation of a cryptocurrency policy. This new policy will permit the company to

Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is ano

Windtree Therapeutics (WINT) has announced its timeline for the interim analysis of the SEISMiC SCAI Stage C Phase 2 study, which is now aimed for July 2025. Th

Cardiogenic shock is a medically urgent condition and drug treatment innovation is desired by providers who treat the condition WARRINGTON, Pa., May 19, 2025

In the first quarter of 2025, Windtree (WINT) laid out a bold new corporate approach aimed at transitioning the company into a revenue-generating entity. The st

WARRINGTON, Pa., May 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (”œWindtree” or ”œthe Company”) (NasdaqCM: WINT), a biotechnology company

PR NewswireSAN DIEGO, May 15, 2025 SAN DIEGO, May 15, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM), today announced

Windtree Therapeutics (WINT) has unveiled new research results highlighting the efficacy of istaroxime, along with a selective SERCA2a activator, in reducing ar

ePoster presentation advances the preclinical evaluation of the importance of SERCA2a function to reduce arrythmias with istaroxime and a selective SERCA2a act

If istaroxime is granted the new chemical entity designation from FDA, it could provide 7.5 years of U.S. exclusivity and additionally the istaroxime U.S. issu

Windtree Therapeutics (WINT) is strategizing to secure significant market protection for its drug istaroxime. The company has sought guidance from patent and FD

Windtree Therapeutics (WINT) has entered into an agreement with an experienced real estate investment group to potentially acquire a 436-unit multifamily reside

**media[611668]**

U.S. stock futures were trading lower on Wednesday, after advancing for three consecutive sessions. Futures of major benchmark indices were lower in premarket trading.

Shares of GameStop Corp. GME rose sharply in today's pre-market trading after reporting better-than-expected fourth-quarter earnings. GameStop reported fourth-...

WARRINGTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (”œWindtree” or the ”œCompany”) (NasdaqCM: WINT), a biotechnology compan

Shares of The AZEK Company Inc. AZEK rose sharply in today's pre-market trading after James Hardie Industries plc JHX announced plans to acquire the company for...

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.63% to 42,230.78 whil...

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up ...